Literature DB >> 7831818

In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice.

A Mehta1, J Maggioncalda, O Bagasra, S Thikkavarapu, P Saikumari, T Valyi-Nagy, N W Fraser, T M Block.   

Abstract

The presence of herpes simplex virus (HSV-1) DNA in the trigeminal ganglia of latently infected mice was detected by an in situ DNA polymerase chain reaction (PCR), which includes a DNA:DNA hybridization step (indirect in situ PCR). These results were compared to the number of neurons possessing the HSV-1 latency associated transcript (LAT), as detected by in situ RNA hybridization with LAT probes. Sensitivity assays were shown to detect a single copy cellular gene in 48% of neuronal cell bodies. The results suggest that in situ PCR is an effective method to locate and detect HSV-1 within latently infected neurons. Moreover, the number of neurons found to be harboring HSV-1, by the method of in situ PCR, which does not depend upon virus gene expression, is within threefold of the number detected by in situ hybridization for LAT. Therefore, this report describes the first detection of HSV-1 DNA in latently infected murine trigeminal ganglia by the method of indirect in situ PCR, and compares the findings to the number of neurons expressing LAT, as assessed by conventional in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831818     DOI: 10.1016/s0042-6822(95)80080-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  62 in total

1.  Quantitative analysis of latent human cytomegalovirus.

Authors:  B Slobedman; E S Mocarski
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection.

Authors:  Xiao-Ping Chen; Marina Mata; Mary Kelley; Joseph C Glorioso; David J Fink
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

3.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 4.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

5.  Localization of herpes simplex virus type 1 DNA in latently infected BALB/c mice neurons using in situ polymerase chain reaction.

Authors:  Behzad Khansarinejad; Hoorieh Soleimanjahi; Amir Ghaemi; Taki Tiraihi; Shahram Pour Beiranvand
Journal:  Iran Biomed J       Date:  2010-07

6.  Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1.

Authors:  L Yang; C C Voytek; T P Margolis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice.

Authors:  Anne M Gussow; Nicole V Giordani; Robert K Tran; Yumi Imai; Dacia L Kwiatkowski; Glenn F Rall; Todd P Margolis; David C Bloom
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

8.  An Immortalized Human Dorsal Root Ganglion Cell Line Provides a Novel Context To Study Herpes Simplex Virus 1 Latency and Reactivation.

Authors:  Nikki M Thellman; Carolyn Botting; Zachary Madaj; Steven J Triezenberg
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

9.  Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency In Vitro.

Authors:  Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency.

Authors:  Dacia L Kwiatkowski; Hilary W Thompson; David C Bloom
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.